Publications:

Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials.

Iscience

Ishikawa, Tomohiko T; Ogawa, Takenori T; Shiihara, Masahiro M; Usubuchi, Hajime H; Omori, Yuko Y; Hirose, Katsuya K; Itoh, Taito T; Yoshida, Takuya T; Nakanome, Ayako A; Okoshi, Akira A; Higashi, Kenjiro K; Ishii, Ryo R; Rokugo, Masahiro M; Wakamori, Shun S; Okamura, Yasunobu Y; Kinoshita, Kengo K; Katori, Yukio Y; Furukawa, Toru T

Publication Date: 2023-05-19

Variant appearance in text: ALK: 3571C>G; Pro1191Ala

PubMed Link: 37207275

Variant Present in the following documents:

• mmc10.xlsx, sheet 1

View BVdb publication page

Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.

Bmc Cancer

Masago, Katsuhiro K; Fujita, Shiro S; Muraki, Miho M; Hata, Akito A; Okuda, Chiyuki C; Otsuka, Kyoko K; Kaji, Reiko R; Takeshita, Jumpei J; Kato, Ryoji R; Katakami, Nobuyuki N; Hirata, Yukio Y

Publication Date: 2015-11-16

Variant appearance in text: ALK: P1191A

PubMed Link: 26572169

Variant Present in the following documents:

• Main text
• 12885_2015_Article_1925.pdf

View BVdb publication page